358 related articles for article (PubMed ID: 2951263)
1. Identification of interleukin 2-producing T helper cells within murine Lyt-2+ T lymphocytes: frequency, specificity and clonal segregation from Lyt-2+ precursors of cytotoxic T lymphocytes.
Heeg K; Steeg C; Hardt C; Wagner H
Eur J Immunol; 1987 Feb; 17(2):229-36. PubMed ID: 2951263
[TBL] [Abstract][Full Text] [Related]
2. Relationship among function, phenotype, and specificity in primary allospecific T cell populations: identification of phenotypically identical but functionally distinct primary T cell subsets that differ in their recognition of MHC class I and class II allodeterminants.
Golding H; Mizuochi T; McCarthy SA; Cleveland CA; Singer A
J Immunol; 1987 Jan; 138(1):10-7. PubMed ID: 2946773
[TBL] [Abstract][Full Text] [Related]
3. Reactivity of Ly-2+ T cells against 2,4,6-trinitrophenyl (TNP)-modified syngeneic stimulator cells: specificity, frequency of interleukin 2-producing Ly-2+ helper T cells and clonal segregation from Ly-2+ cytotoxic T lymphocytes.
Schmitt J; Wagner H; Heeg K
Eur J Immunol; 1988 Mar; 18(3):325-32. PubMed ID: 2965642
[TBL] [Abstract][Full Text] [Related]
4. Frequency analysis of class I MHC-reactive Lyt-2+ and class II MHC-reactive L3T4+ IL 2-secreting T lymphocytes.
Heeg K; Steeg C; Schmitt J; Wagner H
J Immunol; 1987 Jun; 138(12):4121-7. PubMed ID: 3108383
[TBL] [Abstract][Full Text] [Related]
5. Quantitative representation of all T cells committed to develop into cytotoxic effector cells and/or interleukin 2 activity-producing helper cells within murine T lymphocyte subsets.
Pfizenmaier K; Scheurich P; Däubener W; Krönke M; Röllinghoff M; Wagner H
Eur J Immunol; 1984 Jan; 14(1):33-9. PubMed ID: 6229409
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of helper function with anti-Lyt-2 or anti-L3T4 monoclonal antibodies depending on stimulating antigens.
Guimezanes A; Schmitt-Verhulst AM
Eur J Immunol; 1985 Dec; 15(12):1187-91. PubMed ID: 2935405
[TBL] [Abstract][Full Text] [Related]
7. Differential helper and effector responses of Lyt-2+ T cells to H-2Kb mutant (Kbm) determinants and the appearance of thymic influence on anti-Kbm CTL responsiveness.
Mizuochi T; Munitz TI; McCarthy SA; Andrysiak PM; Kung J; Gress RE; Singer A
J Immunol; 1986 Nov; 137(9):2740-7. PubMed ID: 2944960
[TBL] [Abstract][Full Text] [Related]
8. Lyt-2+ cells. Requirements for concanavalin A-induced proliferation and interleukin 2 production.
Kern DE; Lachmann LB; Greenberg PD
J Immunol; 1987 Nov; 139(9):2880-7. PubMed ID: 2959723
[TBL] [Abstract][Full Text] [Related]
9. Search for class II major histocompatibility complex molecular involvement in the response of Lyt-2+ cytotoxic T lymphocyte precursors to alloantigen.
Romani L; Mage MG
Eur J Immunol; 1985 Nov; 15(11):1125-30. PubMed ID: 2933265
[TBL] [Abstract][Full Text] [Related]
10. Role of cytotoxic T lymphocytes in the prevention of lupus-like disease occurring in a murine model of graft-vs-host disease.
Via CS; Sharrow SO; Shearer GM
J Immunol; 1987 Sep; 139(6):1840-9. PubMed ID: 2957440
[TBL] [Abstract][Full Text] [Related]
11. Signal requirements for the in vitro differentiation of cytotoxic T lymphocytes (CTL): distinct soluble mediators promote preactivation of CTL-precursors, clonal growth and differentiation into cytotoxic effector cells.
Hardt C; Diamantstein T; Wagner H
Eur J Immunol; 1985 May; 15(5):472-8. PubMed ID: 3158532
[TBL] [Abstract][Full Text] [Related]
12. Requirements for the generation of a Lyt-2+ T-cell proliferative response to a syngeneic tumor in the absence of L3T4+ T-cells.
Kern DE; Klarnet JP; Cheever MA; Greenberg PD
Cancer Res; 1990 Oct; 50(19):6256-63. PubMed ID: 2144789
[TBL] [Abstract][Full Text] [Related]
13. Antibodies to the L3T4 and Lyt-2 molecules interfere with antigen receptor-driven activation of cloned murine T cells.
Moldwin RL; Havran WL; Nau GJ; Lancki DW; Kim DK; Fitch FW
J Immunol; 1987 Aug; 139(3):657-64. PubMed ID: 2955046
[TBL] [Abstract][Full Text] [Related]
14. Graft-vs-host reaction limited to a class II MHC difference results in a selective deficiency in L3T4+ but not in Lyt-2+ T helper cell function.
Moser M; Mizuochi T; Sharrow SO; Singer A; Shearer GM
J Immunol; 1987 Mar; 138(5):1355-62. PubMed ID: 2949013
[TBL] [Abstract][Full Text] [Related]
15. Lethal graft-vs-host disease across major histocompatibility barriers: requirement for leucyl-leucine methyl ester sensitive cytotoxic T cells.
Thiele DL; Charley MR; Calomeni JA; Lipsky PE
J Immunol; 1987 Jan; 138(1):51-7. PubMed ID: 2946780
[TBL] [Abstract][Full Text] [Related]
16. A rat anti-mouse T4 monoclonal antibody (H129.19) inhibits the proliferation of Ia-reactive T cell clones and delineates two phenotypically distinct (T4+, Lyt-2,3-, and T4-, Lyt-2,3+) subsets among anti-Ia cytolytic T cell clones.
Pierres A; Naquet P; Van Agthoven A; Bekkhoucha F; Denizot F; Mishal Z; Schmitt-Verhulst AM; Pierres M
J Immunol; 1984 Jun; 132(6):2775-82. PubMed ID: 6202760
[TBL] [Abstract][Full Text] [Related]
17. Analysis of lymphokine producing T helper cells at the clonal level.
Wagner H; Krönke M; Pfizenmaier K; Röllinghoff M; Scheurich P; Hardt C
Behring Inst Mitt; 1983 May; (72):73-7. PubMed ID: 6242343
[TBL] [Abstract][Full Text] [Related]
18. Effects of monoclonal antibodies directed against murine T lymphocyte cell surface antigens on lymphokine production by cloned T lymphocytes reactive with class I MHC or Mls alloantigens.
Lancki DW; Prystowsky MB; Vogel SN; Beller DI; Dialynas DP; Fitch FW
J Immunol; 1984 Oct; 133(4):2051-7. PubMed ID: 6236262
[TBL] [Abstract][Full Text] [Related]
19. Property of class I H-2 alloantigen-reactive Lyt-2+ helper T cell subset. Abrogation of its proliferative and IL-2-producing capacities by intravenous injection of class I H-2-disparate allogeneic cells.
Sato S; Azuma T; Shimizu J; Shima J; Kitagawa S; Hamaoka T; Fujiwara H
J Immunol; 1988 Aug; 141(3):721-7. PubMed ID: 2456330
[TBL] [Abstract][Full Text] [Related]
20. Specificity, phenotype, and precursor frequency of primary cytolytic T lymphocytes specific for class II major histocompatibility antigens.
Golding H; Singer A
J Immunol; 1985 Sep; 135(3):1610-5. PubMed ID: 3874902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
